Keeping you up to date with the very latest from Nova Laboratories. Click on the news article to read more.
NOVA LABS on Ebola crisis: Once the pharma market has found a safe and effective Ebola vaccine or treatment,...
Nova had a very successful evening at the recent Insider’s Midlands International Trade Awards, winning two...
Nova is proud to announce that our HydRIS® vaccine stabilisation device has been awarded a US patent. HydRIS...
A drug developed by a Leicestershire company will help hundreds of children suffering from cancer in...
Nova will be exhibiting at The Pharmacy Show at the NEC in October. Please come and visit us at stand PE71
Specialist pharmaceutical and medical technologies business, LINK Healthcare (‘LINK’) has secured marketing...
Nova Laboratories will be attending the NOPHO meeting in Norway, 10-13 May 14, as part of Nova’s continued...
Nova Laboratories attended the IPHOUM meeting in Edinburgh in May 14, as part of Nova’s continued commitment to...
Nova Laboratories has secured U.S Food and Drug Administration (FDA) approval for its acute lymphoblastic leukaemia...
Nova Laboratories Ltd will be exhibiting at ‘Spray Drying Solutions for the Pharmaceutical Industry’ in...
Breaking news: Nova laboratories is proud to announce that Purixan (TM) has received FDA approval for sale in the US....
Wednesday 16th April – Business as usual, last day for fridge lines Thursday 17th April – Business hours...
The launch by Nova of two stabilization and drug delivery platforms that have the potential to revolutionize the...
Nova Labs will be attending the Clinical Pharmacy Show for the 3rd successive year, please visit us at stand F25
Nova Laboratories Ltd will be participating at the Annual International Injectable Drug Delivery Conference in...
Nova is pleased to announce we will be attending the following events this year. Clinical Pharmacy Congress,...